![](https://investorshub.advfn.com/uicon/200692.png?cb=1486982540)
Friday, May 08, 2020 9:17:17 AM
Not the way you would think the CEO of a Global Medical Device Company would act.
No, but it is the way a two-bit mom and pop (or mom and daughter) share selling scheme would act - and that is the impression being given to prospective shareholders.
The market reaction to the nirvana of full-body FDA approval is very telling. Clearly no new investors came near the stock for what should have been earth shattering news. I was fortunate enough hold shares in a company that was anticipating (and obtained) FDA approval for a drug. What an incredible ride.....what did BIEL get? A two-day spike and a path to oblivion. Why? Flippers taking advantage of the abysmal share structure, zero interest from new long-term investors to hold the price surge, and frustrated longs taking what might be one of their last opportunities to bail with at least some of their money.
The company's entire history, outside it's five FDA approvals, has been one of complete incompetence and utter failure. Here is sits - .0005, no deals, complete silence, and a CEO more interest in squabbling with shareholders and riding her bike than doing something to market what is, by all accounts, a remarkable technology.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM